Nicolab and Wellumio Sign Memorandum of Understanding to Advance Stroke Care Innovation

MELBOURNE, AUSTRALIA – Nicolab, a leading provider of digital telehealth solutions for advancing stroke workflow, and Wellumio, a pioneering medical device company specialising in portable imaging technology, are pleased to announce the signing of a Memorandum of Understanding (MOU). This strategic collaboration aims to explore the integration of Wellumio’s Axana portable MRI device with Nicolab’s StrokeViewer platform to enhance rapid stroke diagnosis and streamline clinical workflows.

The partnership marks a significant step forward in improving stroke care by leveraging AI-powered image analysis and portable imaging to provide real-time decision support for clinicians. By bringing advanced imaging directly to the point of care, this collaboration has the potential to significantly reduce treatment delays and improve patient outcomes, particularly in regional and remote areas.

Nicolab’s StrokeViewer is a globally recognised platform that enables seamless image sharing, AI-driven stroke detection, and remote decision-making support for clinicians. Wellumio’s Axana device, currently undergoing clinical trials in Australia, is designed to provide fast, high-quality portable imaging, enabling earlier intervention and improved stroke triage.

This collaboration comes at a pivotal time for Nicolab, following its recent success in securing a Standing Offer Arrangement (SOA) with Queensland Health to deploy StrokeViewer across 36 hospitals, making it the largest AI-powered stroke imaging rollout in Australia. This initiative, part of Queensland’s $5.8 million annual Telestroke Service, will provide life-saving stroke care to over two million regional and remote Queenslanders. The deployment underscores Nicolab’s capability to deliver enterprise-grade, clinically integrated AI solutions at scale.

“We are excited to explore this collaboration with Wellumio,” said Michael Macilquham, CEO at Nicolab. “The combination of our AI-powered StrokeViewer solution with Wellumio’s cutting-edge portable imaging technology has the potential to revolutionise stroke care, ensuring patients receive the fastest and most accurate diagnosis possible. With our recent Queensland Health deployment, we are further demonstrating the power of AI-driven stroke diagnosis to transform patient outcomes across the country.”

Shiek Tzeng, Co-founder and CEO at Wellumio, added, “Our Axana device is designed to bring critical imaging closer to patients, and integrating it with StrokeViewer could provide clinicians with unprecedented access to real-time stroke diagnostics and decision-making tools. This partnership aligns perfectly with our mission to enhance stroke care accessibility and efficiency.”

The MOU outlines the establishment of a joint steering committee to oversee the feasibility assessment of the integration, covering technical requirements, clinical pathways, and commercial models. Both parties will collaborate to explore funding opportunities and regulatory pathways to support the potential deployment of this combined solution.

By combining expertise in AI-driven telehealth solutions and point-of-care imaging, Nicolab and Wellumio are poised to set a new standard for stroke care in Australia and beyond.